Fig. 3

Improvements in BCVA from baseline to end of the study. BCVA best corrected visual acuity, ITT intent-to-treat population, PP per-protocol population
Improvements in BCVA from baseline to end of the study. BCVA best corrected visual acuity, ITT intent-to-treat population, PP per-protocol population